K.O. for TB?
Each year, tuberculosis strikes about nine million people worldwide; about two million die from the persistent infection. The disease is becoming deadlier as more strains of the TB bacterium develop resistance to the drugs used to treat it. And the only vaccine against TB, derived from the TB bacteria that infect cows, is often ineffective: in recent tests, the vaccine protected fewer than half of those immunized.
Immunologist William Jacobs and his coworkers at New York’s Albert Einstein College of Medicine may have found a way to fortify our crumbling defenses against TB. Jacobs has created a vaccine based on the TB bacterium that infects humans; by using mutant strains of the bacterium, he has made a vaccine that he describes as safe yet far more effective than ones based on the cow TB bacteria. Jacobs hopes to have the vaccine in clinical trials within a year.
Keep Reading
Most Popular
Large language models can do jaw-dropping things. But nobody knows exactly why.
And that's a problem. Figuring it out is one of the biggest scientific puzzles of our time and a crucial step towards controlling more powerful future models.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Google DeepMind’s new generative model makes Super Mario–like games from scratch
Genie learns how to control games by watching hours and hours of video. It could help train next-gen robots too.
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.